Overview
Specialty insurance broker Ryan Specialty's Q3 revenue grows 24.8% yr/yr, beating analysts' expectations
Company attributes revenue growth to organic growth and strategic investments
However, Adjusted EPS for Q3 misses expectations
Outlook
Company guides to double-digit organic revenue growth for full year 2025
Company expects adjusted EBITDAC margin to be flat to modestly down for 2025
Result Drivers
ORGANIC GROWTH - Co cites new client wins and expanded relationships as key drivers of 15% organic revenue growth
ACQUISITIONS - Revenue growth supported by contributions from recent M&A transactions
EXPENSE INCREASES - Higher compensation and benefits expenses due to increased headcount and revenue growth
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $754.57 mln | $741 mln (10 Analysts) |
Q3 Adjusted EPS | Miss | $0.47 | $0.48 (14 Analysts) |
Q3 Adjusted Net Income | $131.70 mln | ||
Q3 Net Income | $62.60 mln | ||
Q3 Operating Income | $110.79 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the multiline insurance & brokers peer group is "buy"
Wall Street's median 12-month price target for Ryan Specialty Holdings Inc is $70.00, about 27.3% above its October 29 closing price of $50.87
Press Release: ID:nBwRBfmsa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)